Co-Diagnostics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Co-Diagnostics, Inc. (CODX) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Current Assets
Cash and Cash Equivalents2.9414.9222.9788.6147.31
Short-Term Investments26.8143.6358.291.264.34
Cash & Short-Term Investments29.7558.5581.2689.8647.31
Accounts Receivable0.130.303.4520.9112.14
Inventory1.071.665.312.008.00
Other Current Assets1.341.600.762.340.45
Total Current Assets32.2962.1492.73115.1267.81
Non-Current Assets
Property, Plant & Equipment (Net)4.886.002.911.932.88
Long-Term Investments0.730.770.671.001.93
Goodwill0.000.000.0014.710.00
Intangible Assets26.1026.4026.7727.200.00
Other Non-Current Assets0.000.000.0020.990.00
Total Non-Current Assets31.7133.1830.3544.913.42
Total Assets64.0095.32123.09160.0371.24
Current Liabilities
Accounts Payable3.291.480.950.613.76
Short-Term Debt0.920.000.000.000.00
Accrued Liabilities2.562.170.933.862.97
Deferred Revenue0.040.360.000.150.31
Other Current Liabilities0.500.891.695.770.45
Total Current Liabilities7.325.753.8712.604.06
Non-Current Liabilities
Long-Term Debt1.242.150.050.000.00
Deferred Tax Liabilities0.000.002.427.230.00
Other Non-Current Liabilities1.140.751.045.730.03
Total Non-Current Liabilities2.373.564.6912.960.48
Total Liabilities9.699.318.5725.564.54
Stockholders' Equity
Common Stock0.040.040.030.030.03
Retained Earnings-33.044.6039.9354.1717.51
Accumulated Other Comprehensive Income0.420.150.290.000.00
Treasury Stock-15.5815.5814.210.000.00
Additional Paid-in Capital102.4796.8188.4780.2749.16
Shares Outstanding1.101.041.031.130.00
Total Stockholders' Equity54.3186.01114.52134.4866.70
Total Liabilities & Equity64.0095.32123.09160.0371.24